Enovis CORP (ENOV) stock
ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)
Close on Nov 18, 2026Market cap $1.56BP/E –Yield –
Enovis operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Enovis's operating income for the twelve months ending Jul 3, 2026 was -$1.04B. For fiscal 2025 it was -$1.12B. The highest annual figure on record is $409.55M in fiscal 2014.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.12B | – |
| FY2024 | Dec 31, 2024 | -$775.72M | – |
| FY2023 | Dec 31, 2023 | -$65.71M | – |
| FY2022 | Dec 31, 2022 | -$71.18M | – |
| FY2021 | Dec 31, 2021 | -$62.80M | – |
| FY2020 | Dec 31, 2020 | -$66.18M | -132.5% |
| FY2019 | Dec 31, 2019 | $203.61M | +34.4% |
| FY2018 | Dec 31, 2018 | $151.54M | +11.8% |
| FY2017 | Dec 31, 2017 | $135.60M | -42.7% |
| FY2016 | Dec 31, 2016 | $236.85M | -10.8% |
| FY2015 | Dec 31, 2015 | $265.62M | -35.1% |
| FY2014 | Dec 31, 2014 | $409.55M | +0.8% |
| FY2013 | Dec 31, 2013 | $406.39M | +190.3% |
| FY2012 | Dec 31, 2012 | $140.01M | +440.5% |
| FY2011 | Dec 31, 2011 | $25.91M | -24.6% |
| FY2010 | Dec 31, 2010 | $34.37M | -13.3% |
| FY2009 | Dec 31, 2009 | $39.63M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 3, 2026 | $17.41M | – |
| Q1 FY2026 | Apr 3, 2026 | $6.53M | – |
| Q4 FY2025 | Dec 31, 2025 | -$502.18M | – |
| Q3 FY2025 | Oct 3, 2025 | -$558.49M | – |
| Q2 FY2025 | Jul 4, 2025 | -$16.80M | – |
| Q1 FY2025 | Apr 4, 2025 | -$46.77M | – |
| Q4 FY2024 | Dec 31, 2024 | -$664.75M | – |
| Q3 FY2024 | Sep 27, 2024 | -$31.74M | – |
| Q2 FY2024 | Jun 28, 2024 | -$44.22M | – |
| Q1 FY2024 | Mar 29, 2024 | -$35.01M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.76M | – |
| Q3 FY2023 | Sep 29, 2023 | -$20.49M | – |
| Q2 FY2023 | Jun 30, 2023 | -$14.49M | -361.0% |
| Q1 FY2023 | Mar 31, 2023 | -$24.97M | – |
| Q4 FY2022 | Dec 31, 2022 | -$28.19M | – |
| Q3 FY2022 | Sep 30, 2022 | -$17.92M | – |
| Q2 FY2022 | Jul 1, 2022 | $5.55M | – |
| Q1 FY2022 | Apr 1, 2022 | -$30.63M | -150.0% |
| Q4 FY2021 | Dec 31, 2021 | -$18.21M | – |
| Q3 FY2021 | Oct 1, 2021 | -$16.11M | -126.0% |
| Q2 FY2021 | Jul 2, 2021 | -$10.35M | – |
| Q1 FY2021 | Apr 2, 2021 | $61.31M | +30.9% |
| Q4 FY2020 | Dec 31, 2020 | -$170.03M | -285.0% |
| Q3 FY2020 | Oct 2, 2020 | $61.93M | -8.7% |
| Q2 FY2020 | Jul 3, 2020 | -$4.92M | -111.8% |
| Q1 FY2020 | Apr 3, 2020 | $46.84M | +1907.6% |
| Q4 FY2019 | Dec 31, 2019 | $91.88M | +243.3% |
| Q3 FY2019 | Sep 27, 2019 | $67.86M | +93.6% |
| Q2 FY2019 | Jun 28, 2019 | $41.53M | -8.6% |
| Q1 FY2019 | Mar 29, 2019 | $2.33M | -96.2% |
| Q4 FY2018 | Dec 31, 2018 | $26.77M | – |
| Q3 FY2018 | Sep 28, 2018 | $35.06M | -53.1% |
| Q2 FY2018 | Jun 29, 2018 | $45.42M | -35.2% |
| Q1 FY2018 | Mar 31, 2018 | $62.17M | +3.2% |
| Q4 FY2017 | Dec 31, 2017 | -$69.51M | -217.0% |
| Q3 FY2017 | Sep 29, 2017 | $74.77M | +27.3% |
| Q2 FY2017 | Jun 30, 2017 | $70.12M | – |
| Q1 FY2017 | Mar 31, 2017 | $60.22M | – |
| Q4 FY2016 | Dec 31, 2016 | $59.43M | – |
| Q3 FY2016 | Sep 30, 2016 | $58.71M | – |
See a number that looks wrong?